Association between salivary endocannabinoid levels and caries experience in adults
Originally at sciencedirect.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Elevated salivary endocannabinoid levels correlate with lower caries experience in adults, suggesting a potential future chair-side biomarker or risk-stratification tool that could reshape preventive protocols in general and pediatric practices.
Key points
- Authors from Trakya University (Turkey) report the association in JADA, available online 13 Aug 2026; peer-reviewed primary research.
- Study population: adults; salivary anandamide and 2-arachidonoylglycerol measured via LC-MS/MS and compared with DMFT scores.
- Higher endocannabinoid concentrations were statistically linked to lower lifetime caries burden, independent of age, sex, and salivary flow.
- If validated, chair-side endocannabinoid assays could join existing caries-risk assessments used by general dentists and DSO hygiene programs.
Who should care
Read the original on Journal of the American Dental Association (JADA)
Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.
Related
- ·Research
A 76-year-old man with a rapidly enlarging, erythematous gingival lesion
- ·Research
Operationalizing space dentistry: A policy framework for long-duration human spaceflight
- ·Research
Pulpal calcification: A systematic review and meta-analysis evaluating differences among repair materials and the association with vital pulpal therapy success
- ·Clinical
Antibiotic stewardship: balancing patient care and public health: American Dental Association Council on Scientific Affairs Clinical Practice Statement